EXOZ Insider Trading Activity and SEC Form 4 Filings
EXOZ insider trading summary
Over the past 12 months, insiders at Exozymes Inc. (EXOZ) reported 5 open-market purchases worth $6K by 1 insider and 3 sales worth $35K by 2 insiders on SEC Form 4. Net insider selling was $28K.
Latest EXOZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Damien Alan Perriman | Chief Commercial Officer | Sell | $19K (3,729 @ $5.21) |
| Aug 26, 2026 | Michael Heltzen | Chief Executive Officer | Buy | $2K (251 @ $7.35) |
| Aug 26, 2026 | Michael Heltzen | Chief Executive Officer | Buy | $30 (4 @ $7.58) |
| Aug 26, 2026 | Michael Heltzen | Chief Executive Officer | Buy | $2K (250 @ $7.60) |
| Aug 25, 2026 | Michael Heltzen | Chief Executive Officer | Buy | $2K (250 @ $7.52) |
| Aug 25, 2026 | Michael Heltzen | Chief Executive Officer | Buy | $750 (100 @ $7.50) |
| Apr 9, 2026 | Tyler Paz Korman | Chief Scientific Officer | Sell | $8K (750 @ $10.53) |
| Apr 8, 2026 | Tyler Paz Korman | Chief Scientific Officer | Sell | $8K (750 @ $10.04) |
| Jul 2, 2025 | Michael Heltzen | Chief Executive Officer | Buy | $11K (1,040 @ $10.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.